Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Serum Laboratory Studies, Stool Test, Breath Test01:30

Serum Laboratory Studies, Stool Test, Breath Test

672
Gastrointestinal (GI) diagnostic studies are pivotal in confirming, ruling out, diagnosing, or staging various diseases, including cancers. Following diagnosis, allocating time for discussions with the patient and providing informational resources is crucial. Diagnostic assessments of the GI tract often occur in outpatient settings like endoscopy suites or GI labs. Preparation for these tests may include dietary restrictions, fasting, liquid bowel preparations, laxatives, enemas, and the...
672
Chronic Pancreatitis II: Collaborative Care01:29

Chronic Pancreatitis II: Collaborative Care

246
The management of chronic pancreatitis is multifaceted, involving a comprehensive approach that includes thorough assessment, diagnostic testing, and a variety of management strategies.
Assessment:
246

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ELEVATED CARBOHYDRATE ANTIGEN 19-9 IN PATIENTS WITH INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS AND CANCER RISK.

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association·2026
Same author

Correction: Automated video recording built into routine clinical practice: What does it take?

Endoscopy international open·2026
Same author

Digitally enriching a screening population for pancreatic cancer using routine blood-based measures and clinical histories.

ArXiv·2026
Same author

Multidisciplinary Team Approach for Managing Pancreatic Cysts: Impact, Bias, and Opportunities for Improvement.

United European gastroenterology journal·2026
Same author

Enhanced Molecular Staging of Pancreatic Cancer Using Methylated DNA Markers in Peritoneal Lavage Fluid.

Journal of surgical oncology·2026
Same author

Socioeconomic deprivation, rurality, and travel distance negatively impact survival in early-stage pancreatic ductal adenocarcinoma but are not associated with stage at diagnosis.

Cancer epidemiology·2026

Related Experiment Video

Updated: Dec 29, 2025

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.9K

Molecular Diagnostics and Testing for Pancreatic Cysts.

Jaime de la Fuente1, Shounak Majumder2

  • 1Division of Gastroenterology and Hepatology, Mayo Clinic College of Medicine and Sciences, 200 First St SW, Rochester, MN, 55905, USA.

Current Treatment Options in Gastroenterology
|January 29, 2020
PubMed
Summary

Novel molecular markers show promise for diagnosing advanced neoplasia in pancreatic cystic lesions (PCLs). Research is ongoing to validate these biomarkers in cyst fluid, pancreatic juice, and blood for improved patient care.

Keywords:
BiomarkerDiagnosticIPMNMolecularPancreatic cyst

More Related Videos

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

1.2K
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.8K

Related Experiment Videos

Last Updated: Dec 29, 2025

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma
05:44

Isolation of Proximal Fluids to Investigate the Tumor Microenvironment of Pancreatic Adenocarcinoma

Published on: November 5, 2020

4.9K
A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions
09:00

A Streamlined Approach for Mass Spectrometry-Based Proteomics Using Selected Tissue Regions

Published on: April 18, 2025

1.2K
DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens
10:38

DIPLOMA Approach for Standardized Pathology Assessment of Distal Pancreatectomy Specimens

Published on: February 1, 2020

7.8K

Area of Science:

  • Gastroenterology and Hepatology
  • Oncology
  • Molecular Diagnostics

Background:

  • Current guidelines for pancreatic cystic lesions (PCLs) combine clinical and imaging findings.
  • These guidelines effectively identify low-risk PCLs but have limited accuracy for advanced neoplasia in high-risk lesions.
  • Novel molecular markers are needed to improve the diagnosis and management of PCLs.

Purpose of the Study:

  • To review the recent medical literature on molecular diagnostics of PCLs.
  • To summarize molecular biomarkers assayed in cyst fluid, pancreatic juice, and blood.
  • To highlight the potential of molecular markers in transforming PCL patient care.

Main Methods:

  • Literature review of recent studies on molecular diagnostics for PCLs.
  • Summary of genetic, epigenetic, and protein biomarkers identified in cyst fluid.
  • Inclusion of biomarkers from pancreatic juice and blood in early-stage studies.

Main Results:

  • Promising early results exist for genetic, epigenetic, and protein biomarkers in cyst fluid for histologic diagnosis and advanced neoplasia detection.
  • Most studies used archival cyst fluid, with few independent validation sets.
  • Multicenter prospective validation studies are pending to define optimal marker combinations.
  • Biomarkers in pancreatic juice and blood are in early research phases.

Conclusions:

  • The field of molecular diagnostic biomarkers for PCLs is rapidly evolving.
  • Promising candidate markers are undergoing prospective evaluation.
  • Novel molecular markers, combined with advanced imaging, are expected to transform PCL management and improve patient outcomes.